Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

AstraZeneca (AZNL)

Add To Portfolio

0.000p

Closing Price Chg:

-228.00p
52 Week High: 13,250.00p
52 Week Low: 9,642.00p

Currency: UK Pounds
Shares Issued: 1,264.16m
Volume: 0

AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

Brands:

Losec, Prilosec, Nexium, Crestor

Key Personnel

Senior Independent Non-Executive Director:	Philip A J Broadley
CEO and Executive director:	Pascal Soriot
CFO & Executive Director:	Aradhana Sarin
Chairman:	Michel Demare
Independent Non-Executive Director:	Euan Ashley
Independent Non-Executive Director:	Sheri McCoy
Independent Non-Executive Director:	Diana Layfield
Independent Non-Executive Director:	Tony Mok
Independent Non-Executive Director:	Nazneen Rahman
Non-Executive Dir:	Anna Manz, Rene Haas, Birgit Conix , Marcus Wallenberg, Karen Knudsen

Contact Details

Address:	1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge,United Kingdom, CB2 0AA
Phone:	+44 (0)20 3749 5000
Fax:	+44 (0)20 7604 8151
Website:	http://www.astrazeneca.com

Listings

Overseas Listings:	LSE:AZN
ISIN:	GB0009895292

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

AstraZeneca Market Data

Currency	UK Pounds
Share Price	11,120.00p
Closing Price Change	-228.00p
% Change	0.00 %
52 Week High	13,250.00p
52 Week Low	9,642.00p
Volume	0
Shares Issued	1,264.16m